Introduction
Schwannoma (Neurilimoma) Malignant (SWM) is also called malignant tumor of nerve cells, neurogenic sarcoma or neurofibrosarcoma. It is a tumor that develops from schwann cells (the sheath of the nerves) [1] . The schwannomas of the digestive tract remain rare and are mainly represented by gastric localizations [2, 3] .
Gastric schwannoma accounts for only 0.2% of all gastric neoplasms. it is a benign tumor with an excellent prognosis after total resection [4] . Although the majority of schwannomas are benign, there are malignant forms, so-called malignant tumors of peripheral nerve sheaths which is the case of our patient [5] [6] [7] [8] [9] [10] [11] . We report the case of a 70 years old women with gastric malignant schwannoma and discuss the anatomopathological and evolutionary clinical features of this tumor entity.
Case Report
We report the case of a 70-years-old woman with a medical history of of hyperthyroidism under neo mercazol. 
Discussion
Gastric schwannoma is the most common among digestive schwannomas. But it represents only 0.2% of all gastric tumors,
These tumors meet at all ages of life. But, usually occur between 40 to 60 years, with an average of 58 years. According to the series, we find a female preponderance [12] [13] [14] [15] as is the case of our patient, wich a sex-ratio equal 1 [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . The development of gastric schwannoma is low noise. It is often asymptomatic, and its discovery is most often fortuitous during a surgical procedure or a radiological or endoscopic examination [26] . In all the cases described in the literature, no specific symptomatology could be established to differentiate the SG from other gastric tumor lesions Recklinghausen's disease. The macroscopic appearance of gastric schwannomas presents itself as a firm, usually encapsulated tumor, well circumscribed, in the form of a multi-lobed, spherical or ovoid, developed along a nerve or eccentric, displacing the nerve fibers but never invading them, however this description "Is not specific [19, 20] . In the gastric wall: usually found in the submucosa or muscularis, which are repressed, dissociated by the tumor. Its base of implantation can be sessile or pediculated [19] , The capsule can be missing in some cases. [15] . The size of the tumor varies between 0.5 and 15.5cm in diameter [21, 22] . At the cut, it appears, pearlywhite, yellowish or gray, even variegated in case of fatty infiltrate, necrotic or haemorrhagic zones [15] .
Immunohistochemistry makes it possible to establish the diagnosis: the highly positive immunoreactivity to PS100 is compatible with a schwannoma (GISTs also express S100 in 10% of cases), other markers can be used. Nevertheless, the search for c-kit and CD34 is fundamental in order to eliminate GIST and, in the case of c-kit negativity, it is possible to carry out a specific mutation search for the kit and PDGFRA genes [6, 7, 9] .
At immunohistochemistry schwannomas are still strongly positive for S100 protein. Sometimes only the evolution and the appearance of metastases make it possible to affirm the malignancy [10] . This was the case in our patient.
The elements suggesting malignancy are: the large size of the tumor, the break-in of the capsule, the adherence to neighboring organs, the calcifications and the necrotic haemorrhagic changes, the hypercellularity, the high mitotic activity of the appearance epithelioid and sometimes the diagnosis of malignancy is established only on the existence of metastases. The prognosis of gastric schwannomas is difficult to assess because of the exceptional nature or the scarcity of reported cases. According to STOUT [27] , malignant forms are always straight off. For others, it is the degeneration of a benign Schwannian tumor [25, [28] [29] [30] [31] .
Complete surgical removal of the tumor is the gold standard.
This removal can be difficult and sometimes incomplete due to intimate contact with large vessels or noble organs. Our patient was not able to benefit from a curative treatment due to the presence of several distant metastases. Remote metastases are localized to the lungs, liver and bones. They appear within an average of two years, which is shorter as long as there is an NF1 [32, 33, 21] .
The first-line chemotherapy is based on anthracyclines. So far, it has not been shown that multidrug therapy is superior to doxorubicin monotherapy alone in overall survival. Therefore, chemotherapy with anthracyclines and ifosfamide may be the treatment of choice. MPNST responds poorly to radiotherapy and / or chemotherapy, however, this treatment must be undertaken [29, 30, 31] . The prognosis of gastric MPNST is poor and is associated with a rapid progression of the disease and a poor response to chemotherapy. Most patients die within 2 years, with an average 5-year survival rate of 23% [34] . In view of the reserved prognosis of these malignant tumors, surveillance of these patients is essential [24] .
Conclusion
Gastric schwannoma is one of the rare mesenchymal tumors.
Its diagnosis is often late and difficult to establish preoperatively because of the absence of clinical, biological and radiological specificity of this tumor type, only the histopathological examination with immunohistochemical study allows establish the diagnosis of certainty.
The prognosis of mesenteric schwannomas is difficult to assess because of the exceptional nature or rarity of cases reported in the literature.
